Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan A Farr

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Free Radical Biology & Medicine|June 20, 2013
Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics studyAda Fiorini, Rukhsana Sultana, Sarah Förster, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 13, 2008
Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke modelsDilek Dogrukol-Ak, Vijaya B Kumar, Jan S Ryerse, et al.
Journal of Alzheimer'S Disease : JAD|May 13, 2009
Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognitionLaura B Jaeger, Shinya Dohgu, Mark C Hwang, et al.
RSC Medicinal Chemistry|August 30, 2021
Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatmentWilliam L Neumann, Karin E Sandoval, Shirin Mobayen, et al.
The Journal of Biological Chemistry|July 31, 2020
Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restrictionSubhashis Banerjee, Sarbani Ghoshal, Joseph R Stevens, et al.
Redox Biology|November 26, 2021
Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanismChangjun Yang, Bianca P Lavayen, Lei Liu, et al.
NPJ Aging and Mechanisms of Disease|August 31, 2021
Adropin correlates with aging-related neuropathology in humans and improves cognitive function in aging miceSubhashis Banerjee, Sarbani Ghoshal, Clemence Girardet, et al.
Brain, Behavior, and Immunity|January 22, 2023
Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's diseaseMichelle A Erickson, Aric F Logsdon, Elizabeth M Rhea, et al.
Nature Neuroscience|February 24, 2006
Ghrelin controls hippocampal spine synapse density and memory performanceSabrina Diano, Susan A Farr, Stephen C Benoit, et al.
The Journal of Biological Chemistry|November 19, 2023
Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translationGeetika Aggarwal, Subhashis Banerjee, Spencer A Jones, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Free Radical Biology & Medicine|June 20, 2013
Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics studyAda Fiorini, Rukhsana Sultana, Sarah Förster, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 13, 2008
Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke modelsDilek Dogrukol-Ak, Vijaya B Kumar, Jan S Ryerse, et al.
Journal of Alzheimer'S Disease : JAD|May 13, 2009
Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognitionLaura B Jaeger, Shinya Dohgu, Mark C Hwang, et al.
RSC Medicinal Chemistry|August 30, 2021
Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatmentWilliam L Neumann, Karin E Sandoval, Shirin Mobayen, et al.
The Journal of Biological Chemistry|July 31, 2020
Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restrictionSubhashis Banerjee, Sarbani Ghoshal, Joseph R Stevens, et al.
Redox Biology|November 26, 2021
Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanismChangjun Yang, Bianca P Lavayen, Lei Liu, et al.
NPJ Aging and Mechanisms of Disease|August 31, 2021
Adropin correlates with aging-related neuropathology in humans and improves cognitive function in aging miceSubhashis Banerjee, Sarbani Ghoshal, Clemence Girardet, et al.
Brain, Behavior, and Immunity|January 22, 2023
Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's diseaseMichelle A Erickson, Aric F Logsdon, Elizabeth M Rhea, et al.
Nature Neuroscience|February 24, 2006
Ghrelin controls hippocampal spine synapse density and memory performanceSabrina Diano, Susan A Farr, Stephen C Benoit, et al.
The Journal of Biological Chemistry|November 19, 2023
Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translationGeetika Aggarwal, Subhashis Banerjee, Spencer A Jones, et al.
Pageof 10